Salivary Hepcidin ELISA: NEW and UNIQUE assay launched by DRG!

Mar 4, 2019 | News, Products | 0 comments

DRG is proud to announce the launch of a NEW and UNIQUE assay kit of DRG’s Iron Panel: Salivary Hepcidin RUO (SLV-6082R).

The hormone hepcidin plays an important role in regulating iron metabolism. It is a major regulator of dietary iron absorption and iron distribution in the body. In serum, the bioactive peptide Hepcidin-25 has shown to be a useful biomarker.

Besides its presence in serum, Hepcidin-25 was additionally confirmed to be present in human saliva. Determination of Hepcidin-25 in saliva has the advantage of a non-invasive and stress-free sample collection without the need of medical personnel.

Specifications of the new assay kit Salivary Hepcidin RUO, SLV-6082R:

  • Principle of the Assay: ELISA based on the principle of competitive binding
  • Assay Range: 68.4 – 8,000 pg/mL
  • Reagents: Ready to use, except Calibrators, Controls and Wash Buffer
  • Sample Volume: 100 µL Saliva
  • Incubation Time: 60/30/15 min at room temperature (no shaker needed)

For more information or to buy DRG ELISA kits, please go to our ecommerce store HERE.

Nicole Bowen

Nicole Bowen

Nicole Bowen is the Product Manager located at DRG International’s worldwide headquarters in Springfield, NJ.
Nicole Bowen

News and Updates

Sign Up for Our Newsletter

  • By submitting this form, you are granting: DRG International, Inc., 841 Mountain Avenue, Springfield, NJ, 07081, permission to email you. You may unsubscribe via the link found at the bottom of every email. (See our Email Privacy Policy (http://constantcontact.com/legal/privacy-statement) for details.) Emails are serviced by Constant Contact.

Click the link to learn more about how DRG is certified in the manufacturing and distribution of in-vitro diagnostic reagents used in the diagnosis of autoimmune status, cancer, cardiac markers, disease status, fertility testing, pregnancy testing, diabetes and immune status.